A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia
- 31 December 1991
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 15 (3), 249-256
- https://doi.org/10.1016/0169-6009(91)90130-r
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Two-Site Immunoradiometric Assay for Pth(1–84) Using N and C Terminal Specific Monoclonal AntibodiesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1991
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- Comparison of different dose regimes of aminohydroxypropylidene‐1,1‐ bisphosphonate (APD) in hypercalcaemia of malignancy.British Journal of Clinical Pharmacology, 1989
- Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemiaThe American Journal of Medicine, 1987
- Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in manJournal of Endocrinology, 1986
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calciumCalcified Tissue International, 1982
- HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?The Lancet, 1982
- Predictive Value of Derived Calcium Figures Based on the Measurement of Ionised CalciumAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981
- NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATIONThe Lancet, 1975